aspirin has been researched along with Chronic Kidney Failure in 160 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin resistance and chronic renal failure are both potentially important clinical issues in coronary artery disease." | 9.16 | Renal function and aspirin resistance in patients with coronary artery disease. ( Blann, AD; Kuzniatsova, N; Lip, GY; Velu, S, 2012) |
| "This study was conducted to evaluate preventive effect of a combination of heparin and aspirin on vascular thrombosis and kidney transplant outcomes of pediatric kidney transplant recipients." | 9.16 | Protective effect of heparin and aspirin against vascular thrombosis in pediatric kidney transplants. ( Esfandiar, N; Hoseini, R; Otukesh, H; Sharifian, M, 2012) |
| "Elevated total plasma homocysteine is an independent risk factor for arterial and venous thrombosis in patients with normal renal function." | 7.79 | Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study. ( El-Charabaty, E; El-Sayegh, S; Saifan, C, 2013) |
| "Chronic use of aspirin and statins has been associated with reduced risk of subsequent myocardial infarction (MI)." | 7.76 | Impact of chronic aspirin and statin therapy on presentation of patients with acute myocardial infarction and impaired renal function. ( Arcieri, R; Commisso, C; Lanzillo, C; Lioy, E; Penco, M; Pendenza, G; Quarto, M; Romagnoli, E; Sciahbasi, A; Summaria, F, 2010) |
| " The aims of the present study were: to verify the incidence of Normal Weight Obese (NWO) syndrome; to evaluate by PINI the effect of 8 weeks acetyl salicylic (100 mg/die) and atorvastatin (10 mg/die) combined treatment on chronic inflammation in 52 selected HD patients." | 7.74 | Anti-inflammatory effects of combined treatment with acetyl salicylic acid and atorvastatin in haemodialysis patients affected by Normal Weight Obese syndrome. ( De Angelis, S; De Lorenzo, A; Di Daniele, N; Di Renzo, L; Miani, N; Noce, A; Tozzo, C, 2008) |
| "There have been no randomized trials of cardioprotective therapy after acute myocardial infarction in patients with chronic kidney disease who should be largely eligible for aspirin (acetylsalicylic acid; ASA) and beta-blockers (BB) as a base of therapy." | 7.71 | Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. ( Borzak, S; Garg, M; Hudson, MP; Manley, HJ; McCullough, PA; Sandberg, KR, 2002) |
| " Myopia and the use of nifedipine were found to carry a significant risk of cataract, and renal failure appeared to carry a high risk, though few patients were affected." | 7.67 | Do aspirin-like analgesics protect against cataract? A case-control study. ( Harding, JJ; van Heyningen, R, 1986) |
| "Aspirin was not associated with significant mortality benefit in diabetes sufferers (95% CI 0." | 5.35 | Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome. ( Abbas, A; Barth, JH; Cubbon, RM; Das, R; Gale, CP; Grant, PJ; Hall, AS; Kearney, MT; Morrell, C; Rajwani, A, 2008) |
| "Using the ESRD database and the Cooperative Cardiovascular Project (CCP) database, we identified AMI patients who were receiving either peritoneal dialysis or hemodialysis before admission." | 5.32 | Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. ( Berger, AK; Duval, S; Krumholz, HM, 2003) |
| " During the randomized phase, there were small but significant differences between the groups in BP, proteinuria, LDL cholesterol, and use of aspirin, statins, active vitamin D, and antihypertensive medications, in favor of the intervention group." | 5.19 | Nurse practitioner care improves renal outcome in patients with CKD. ( Blankestijn, PJ; Bots, ML; Kaasjager, KA; Ligtenberg, G; Peeters, MJ; Sijpkens, YW; Sluiter, HE; Ten Dam, MA; van Buren, M; van de Ven, PJ; van den Brand, JA; van Zuilen, AD; Vervoort, G; Vleming, LJ; Wetzels, JF, 2014) |
| "This study was conducted to evaluate preventive effect of a combination of heparin and aspirin on vascular thrombosis and kidney transplant outcomes of pediatric kidney transplant recipients." | 5.16 | Protective effect of heparin and aspirin against vascular thrombosis in pediatric kidney transplants. ( Esfandiar, N; Hoseini, R; Otukesh, H; Sharifian, M, 2012) |
| "Aspirin resistance and chronic renal failure are both potentially important clinical issues in coronary artery disease." | 5.16 | Renal function and aspirin resistance in patients with coronary artery disease. ( Blann, AD; Kuzniatsova, N; Lip, GY; Velu, S, 2012) |
| "A total of 41 Japanese coronary artery disease patients under HD who received aspirin and clopidogrel were enrolled." | 3.91 | High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis. ( Ariyoshi, N; Fujii, K; Fujimoto, Y; Kitahara, H; Kobayashi, Y; Kohno, Y; Nishi, T; Ohno, Y, 2019) |
| "We estimated the effectiveness and safety of antiplatelet drugs (aspirin and clopidogrel) for the prevention of recurrent ischemic stroke in end-stage renal disease patients undergoing dialysis during long-term follow-up after first-time ischemic stroke." | 3.80 | Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis. ( Chen, CY; Huang, YB; Lai, WT; Lee, CT; Lee, KT, 2014) |
| "Elevated total plasma homocysteine is an independent risk factor for arterial and venous thrombosis in patients with normal renal function." | 3.79 | Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study. ( El-Charabaty, E; El-Sayegh, S; Saifan, C, 2013) |
| "Chronic use of aspirin and statins has been associated with reduced risk of subsequent myocardial infarction (MI)." | 3.76 | Impact of chronic aspirin and statin therapy on presentation of patients with acute myocardial infarction and impaired renal function. ( Arcieri, R; Commisso, C; Lanzillo, C; Lioy, E; Penco, M; Pendenza, G; Quarto, M; Romagnoli, E; Sciahbasi, A; Summaria, F, 2010) |
| " The aims of the present study were: to verify the incidence of Normal Weight Obese (NWO) syndrome; to evaluate by PINI the effect of 8 weeks acetyl salicylic (100 mg/die) and atorvastatin (10 mg/die) combined treatment on chronic inflammation in 52 selected HD patients." | 3.74 | Anti-inflammatory effects of combined treatment with acetyl salicylic acid and atorvastatin in haemodialysis patients affected by Normal Weight Obese syndrome. ( De Angelis, S; De Lorenzo, A; Di Daniele, N; Di Renzo, L; Miani, N; Noce, A; Tozzo, C, 2008) |
| "The risk for major bleeding episodes in hemodialysis patients increases significantly while on aspirin and/or warfarin, although warfarin alone did not reach statistical significance." | 3.74 | Major bleeding in hemodialysis patients. ( Day, AG; Harman, GJ; Holden, RM; Holland, D; Wang, M, 2008) |
| "There have been no randomized trials of cardioprotective therapy after acute myocardial infarction in patients with chronic kidney disease who should be largely eligible for aspirin (acetylsalicylic acid; ASA) and beta-blockers (BB) as a base of therapy." | 3.71 | Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. ( Borzak, S; Garg, M; Hudson, MP; Manley, HJ; McCullough, PA; Sandberg, KR, 2002) |
| " Twenty four patients aged 48 +/- 17 years (21 with idiopathic glomerulonephritis, one with systemic lupus erythematosus and two with type II diabetes mellitus) were treated with aspirin and dipyridamole or aspirin alone during 23." | 3.68 | [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?]. ( Duclos, J, 1993) |
| " Myopia and the use of nifedipine were found to carry a significant risk of cataract, and renal failure appeared to carry a high risk, though few patients were affected." | 3.67 | Do aspirin-like analgesics protect against cataract? A case-control study. ( Harding, JJ; van Heyningen, R, 1986) |
| " There was no lysozymuria with severe uraemic heart failure, aspirin and paracetamol poisoning, or severe jaundice, nor in two cases of acute glomerulonephritis." | 3.65 | Lysozymuria and acute disorders of renal function. ( De Silva, KL; Harrison, JF; Parker, RW, 1973) |
| "Anaemia in diabetes mellitus (DM) and/or chronic renal failure (CRF) may be caused by a decreased production of erythropoietin (EPO), EPO resistance, and by the lysis of the young circulating red blood cells (neocytolysis) induced by subclinical inflammation and low EPO level." | 2.73 | Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis. ( Köszegi, T; Laczy, B; Markó, L; Mohás, M; Molnár, GA; Nagy, J; Tamaskó, M; Wagner, L; Wagner, Z; Wittmann, I, 2007) |
| "Management of hypertension in diabetic nephropathy is challenging and generally requires a minimum of three different and complementary antihypertensive agents to achieve the recently recommended blood pressure (BP) goal of <130/80 mm Hg in order to reduce cardiovascular (CV) risk and preserve kidney function." | 2.42 | Diabetes and chronic kidney disease: tragedy and challenge. ( Bakris, GL; Chua, DY, 2004) |
| "She developed aplastic anemia seven weeks after initiation of ticlopidine." | 2.41 | Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review. ( Ammash, Z; Dabajah, B; Mourad, FH; Nasrallah, A; Taher, A, 2000) |
| " Chronic administration of aspirin alone over 18 to 68 weeks in doses of 120 to 500 mg/kg/d has been reported to cause renal papillary necrosis in rats." | 2.39 | Does aspirin cause acute or chronic renal failure in experimental animals and in humans? ( D'Agati, V, 1996) |
| "Active systemic lupus erythematosus, advanced cirrhosis, and chronic renal insufficiency seem to predispose patients to the effects on renal function, and there is direct or indirect evidence in those conditions that prostaglandin synthesis is an important part of the body's attempt to preserve renal blood flow." | 2.36 | Acute effects of aspirin and acetaminophen on renal function. ( Kimberly, RP; Plotz, PH, 1981) |
| "Aspirin resistance was observed in 17 of 109 patients in whom this parameter was measured, and was not significantly associated with VA failure (p = 0." | 1.51 | Effects of aspirin resistance and mean platelet volume on vascular access failure in hemodialysis patients. ( Cho, A; Choi, MJ; Hoon, HC; Koo, JR; Lee, YK; Noh, JW; Yoon, JW, 2019) |
| "The sVEGFR-1 level of ESRD group was significantly higher (0." | 1.48 | Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease. Associations with laboratory findings, comorbidities, and medications. ( Acar, R; Erturk, I; Ozgurtas, T; Saglam, K; Yesildal, F, 2018) |
| "The aims of this study are to find the prevalence of potential drug-drug interactions (DDIs) in patients with Hemodialysis and identify factors associated with these interactions if present." | 1.43 | Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients. ( Abu-Ghazaleh, D; Al-Ramahi, R; Bsharat, A; Raddad, AR; Rashed, AO; Shehab, O; Yasin, E, 2016) |
| "Cerebral venous thrombosis is a rare condition with various clinical presentations which may delay diagnosis." | 1.40 | Thrombosis of the great cerebral vein in a hemodialysis patient. ( Basic-Jukic, N; Gledovic, B; Radunovic, D; Ratkovic, M, 2014) |
| "Clopidogrel and ticlopidine, sometimes in combination with ASA, are associated with a low risk of bleeding during renal transplantation and does not seem to be a contraindication for renal transplant surgery." | 1.40 | Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study. ( Abramowicz, D; Benahmed, A; Broeders, N; Donckier, V; Ghisdal, L; Hoang, AD; Kianda, M; Le Moine, A; Lemy, A; Madhoun, P; Massart, A; Mikhalski, D; Racapé, J; Sadis, C; Wissing, M, 2014) |
| "These results demonstrate the impact of a pharmacist-driven renal medication dosing intervention within a PCMH on medication use and safety for patients with CKD." | 1.40 | Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home. ( Barnes, KD; Beatty, SJ; Lehman, AM; Tayal, NH, 2014) |
| "Patients with ESRD are at higher risk for coronary artery disease (CAD) and also their post-interventional outcome is worse compared to patients with normal renal function." | 1.40 | Haemodialysis impairs clopidogrel but not aspirin responsiveness in patients with end-stage renal disease. Results of a pilot study. ( Bocksch, W; Fateh-Moghadam, S; Gawaz, M; Geisler, T; Htun, P; Kan, T; Mueller, E; Pohle, C; Schindler, R, 2014) |
| "Warfarin treatment was associated with a decreased risk of stroke or systemic thromboembolism among patients with chronic kidney disease, whereas warfarin and aspirin were associated with an increased risk of bleeding." | 1.38 | Stroke and bleeding in atrial fibrillation with chronic kidney disease. ( Gislason, GH; Hommel, K; Kamper, AL; Køber, L; Lane, DA; Lindhardsen, J; Lip, GY; Olesen, JB; Torp-Pedersen, C, 2012) |
| "Aspirin non-response was two-fold more prevalent in haemodialysis patients (42." | 1.37 | Laboratory signs of aspirin response in haemodialysis patients. ( Abaci, O; Arat, A; Gorcin, B; Gurmen, T; Kaya, A; Kilickesmez, KO; Kocas, C; Okcun, B, 2011) |
| "To determine prevalence of central vein stenosis following catheterization with double-lumen temporary catheters, we performed color Doppler sonography in 100 consecutive patients." | 1.36 | Prevalence of central vein stenosis following catheterization in patients with end-stage renal disease. ( Naroienejad, M; Rezvani, A; Saedi, D, 2010) |
| "Aspirin was not associated with significant mortality benefit in diabetes sufferers (95% CI 0." | 1.35 | Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome. ( Abbas, A; Barth, JH; Cubbon, RM; Das, R; Gale, CP; Grant, PJ; Hall, AS; Kearney, MT; Morrell, C; Rajwani, A, 2008) |
| "We report a case of ET and chronic renal failure treated with anagrelide and low-dose aspirin in a patient who did not receive transfusion and surgical intervention due to religious reasons, and had a fatal outcome." | 1.35 | Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis. ( Demulder, AC; Malarme, M; Mesquita, Mdo C; Noubouossie, D; Sol, EB, 2009) |
| "Aspirin use was determined at baseline and one year later." | 1.35 | Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study. ( Akizawa, T; Bragg-Gresham, JL; Elder, SJ; Fukuhara, S; Hasegawa, T; Hugh, RC; Jadoul, M; Pisoni, RL; Port, FK; Yamazaki, S, 2008) |
| "Aspirin was the most frequently prescribed adjoining non-anti-hypertensive drugs (39." | 1.33 | Pattern of drug utilization among hypertensives in a Nigerian teaching hospital. ( Balogun, OB; Yusuff, KB, 2005) |
| "Studies on the association between the long-term use of aspirin and other analgesic and nonsteroidal anti-inflammatory drugs (NSAIDs) and end-stage renal disease (ESRD) have given conflicting results." | 1.33 | Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. ( Ibáñez, L; Laporte, JR; Martínez, MJ; Morlans, M; Vidal, X, 2005) |
| " In contrast to acute renal insufficiency that may already occur after a single NSAID dose, analgesic nephropathy is a disease caused by long-term intake of NSAID compound analgesics and predominantly affects the middle and old age." | 1.33 | [Chronic interstitial nephritis in an 18-year-old due to intake of a compound analgesic]. ( Janssen, U; Jochum, E, 2006) |
| "Using the ESRD database and the Cooperative Cardiovascular Project (CCP) database, we identified AMI patients who were receiving either peritoneal dialysis or hemodialysis before admission." | 1.32 | Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. ( Berger, AK; Duval, S; Krumholz, HM, 2003) |
| "Aspirin therapy was associated with better secondary graft patency (RR, 0." | 1.31 | Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). ( Dykstra, DM; Gillespie, B; Held, PJ; Saran, R; Wolfe, RA; Young, EW, 2002) |
| "We studied 716 patients treated for ESRD and 361 control subjects of similar age from Maryland, Virginia, West Virginia, and Washington, D." | 1.29 | Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. ( Klag, MJ; Perneger, TV; Whelton, PK, 1994) |
| "A 35-year-old patient with symptomatic chronic renal failure secondary to hereditary nephritis underwent heparinization during urgent hemodialysis." | 1.28 | Heparin-induced thrombocytopenia in renal failure. ( Clark, WF; Hall, AV; Parbtani, A, 1992) |
| " This relationship may represent a dose-response curve relating amount of analgesic intake to prevalence of nephropathy." | 1.27 | Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence. ( Buckalew, VM; Schey, HM, 1986) |
| "A renal biopsy showed a severe tubulointerstitial nephritis." | 1.27 | Naproxen-associated renal failure in a child with arthritis and inflammatory bowel disease. ( Balfe, JW; Baumal, R; Laxer, RM; Poucell, S; Silverman, ED, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (28.13) | 18.7374 |
| 1990's | 21 (13.13) | 18.2507 |
| 2000's | 48 (30.00) | 29.6817 |
| 2010's | 42 (26.25) | 24.3611 |
| 2020's | 4 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Okyere, P | 1 |
| Okyere, I | 1 |
| Essuman, G | 1 |
| Attakora, J | 1 |
| Serwaa, D | 1 |
| Donkoh, IE | 1 |
| Ephraim, RKD | 1 |
| Peters, CD | 1 |
| Kjaergaard, KD | 1 |
| Christensen, KL | 1 |
| Bibby, BM | 1 |
| Jespersen, B | 1 |
| Jensen, JD | 1 |
| Wiśniewski, A | 1 |
| Clarkson, SA | 1 |
| Heindl, B | 1 |
| Cai, A | 1 |
| Beasley, M | 1 |
| Dillon, C | 1 |
| Limdi, N | 1 |
| Brown, TM | 1 |
| Erturk, I | 1 |
| Yesildal, F | 1 |
| Acar, R | 1 |
| Ozgurtas, T | 1 |
| Saglam, K | 1 |
| Cho, A | 1 |
| Choi, MJ | 1 |
| Lee, YK | 1 |
| Hoon, HC | 1 |
| Koo, JR | 1 |
| Yoon, JW | 1 |
| Noh, JW | 1 |
| Ohno, Y | 1 |
| Kitahara, H | 1 |
| Fujii, K | 1 |
| Kohno, Y | 1 |
| Ariyoshi, N | 1 |
| Nishi, T | 1 |
| Fujimoto, Y | 1 |
| Kobayashi, Y | 1 |
| Fan, PY | 1 |
| Lee, CC | 1 |
| Liu, SH | 1 |
| Li, IJ | 1 |
| Weng, CH | 1 |
| Tu, KH | 1 |
| Hsieh, MY | 1 |
| Kuo, CF | 1 |
| Chang, TY | 1 |
| Tian, YC | 1 |
| Yang, CW | 1 |
| Wu, HH | 1 |
| Viecelli, AK | 3 |
| Polkinghorne, KR | 3 |
| Pascoe, EM | 2 |
| Paul-Brent, PA | 4 |
| Hawley, CM | 2 |
| Badve, SV | 3 |
| Cass, A | 4 |
| Hooi, LS | 2 |
| Kerr, PG | 3 |
| Mori, TA | 3 |
| Ong, LM | 2 |
| Voss, D | 2 |
| Johnson, DW | 1 |
| Irish, AB | 3 |
| Yamada, S | 1 |
| Yotsueda, H | 1 |
| Nagara, T | 1 |
| Goto, K | 1 |
| Nakashima, Y | 1 |
| Hirakata, H | 1 |
| Fujimi, S | 1 |
| Tsuruya, K | 1 |
| Jeong, CW | 1 |
| Lee, S | 1 |
| Byun, SS | 1 |
| Lee, DH | 1 |
| Lee, SE | 1 |
| Sood, MM | 1 |
| Larkina, M | 1 |
| Thumma, JR | 1 |
| Tentori, F | 1 |
| Gillespie, BW | 1 |
| Fukuhara, S | 2 |
| Mendelssohn, DC | 1 |
| Chan, K | 1 |
| de Sequera, P | 1 |
| Komenda, P | 1 |
| Rigatto, C | 1 |
| Robinson, BM | 1 |
| Aksu, HU | 1 |
| Oner, E | 1 |
| Celik, O | 1 |
| Isiksacan, N | 1 |
| Aksu, H | 1 |
| Uzun, S | 1 |
| Yavuz, D | 1 |
| Ozturk, S | 1 |
| Gul, M | 1 |
| Uslu, N | 1 |
| Saifan, C | 1 |
| El-Charabaty, E | 1 |
| El-Sayegh, S | 2 |
| Ratkovic, M | 1 |
| Basic-Jukic, N | 1 |
| Gledovic, B | 1 |
| Radunovic, D | 1 |
| Fiaccadori, E | 1 |
| Maggiore, U | 1 |
| Regolisti, G | 1 |
| Peeters, MJ | 1 |
| van Zuilen, AD | 1 |
| van den Brand, JA | 1 |
| Bots, ML | 1 |
| van Buren, M | 1 |
| Ten Dam, MA | 1 |
| Kaasjager, KA | 1 |
| Ligtenberg, G | 1 |
| Sijpkens, YW | 1 |
| Sluiter, HE | 1 |
| van de Ven, PJ | 1 |
| Vervoort, G | 1 |
| Vleming, LJ | 1 |
| Blankestijn, PJ | 1 |
| Wetzels, JF | 1 |
| Benahmed, A | 1 |
| Kianda, M | 1 |
| Ghisdal, L | 1 |
| Broeders, N | 1 |
| Massart, A | 1 |
| Lemy, A | 1 |
| Mikhalski, D | 1 |
| Hoang, AD | 1 |
| Donckier, V | 1 |
| Sadis, C | 1 |
| Le Moine, A | 1 |
| Madhoun, P | 1 |
| Racapé, J | 1 |
| Wissing, M | 1 |
| Abramowicz, D | 1 |
| Htun, P | 1 |
| Kan, T | 1 |
| Mueller, E | 1 |
| Pohle, C | 1 |
| Schindler, R | 1 |
| Geisler, T | 1 |
| Gawaz, M | 1 |
| Bocksch, W | 1 |
| Fateh-Moghadam, S | 1 |
| Chen, CY | 1 |
| Lee, KT | 1 |
| Lee, CT | 1 |
| Lai, WT | 1 |
| Huang, YB | 1 |
| Böhlke, M | 1 |
| Giesteira, R | 1 |
| Castilho, C | 1 |
| Pinheiro, B | 1 |
| Irigoyen, MC | 1 |
| Poli de Figueiredo, CE | 1 |
| Barnes, KD | 1 |
| Tayal, NH | 1 |
| Lehman, AM | 1 |
| Beatty, SJ | 1 |
| Jeong, KH | 1 |
| Cho, JH | 1 |
| Woo, JS | 1 |
| Kim, JB | 1 |
| Kim, WS | 1 |
| Lee, TW | 1 |
| Kim, KS | 1 |
| Ihm, CG | 1 |
| Kim, W | 1 |
| Pascoe, E | 1 |
| Hawley, C | 2 |
| Heritier, S | 2 |
| Robertson, A | 2 |
| Seong, HL | 1 |
| Lee, JY | 1 |
| Moon, IT | 1 |
| Lee, HY | 1 |
| Lee, HL | 1 |
| Han, DS | 1 |
| Navarro, MA | 1 |
| Gosch, KL | 1 |
| Spertus, JA | 1 |
| Rumsfeld, JS | 1 |
| Ho, PM | 1 |
| Al-Ramahi, R | 1 |
| Raddad, AR | 1 |
| Rashed, AO | 1 |
| Bsharat, A | 1 |
| Abu-Ghazaleh, D | 1 |
| Yasin, E | 1 |
| Shehab, O | 1 |
| Kataoka, Y | 1 |
| Tsuji, Y | 1 |
| Sakaguchi, Y | 1 |
| Minatsuki, C | 1 |
| Asada-Hirayama, I | 1 |
| Niimi, K | 1 |
| Ono, S | 1 |
| Kodashima, S | 1 |
| Yamamichi, N | 1 |
| Fujishiro, M | 1 |
| Koike, K | 1 |
| Chen, YT | 1 |
| Chen, HT | 1 |
| Hsu, CY | 1 |
| Chao, PW | 1 |
| Kuo, SC | 1 |
| Ou, SM | 1 |
| Shih, CJ | 1 |
| Chen, DC | 1 |
| Singh, GD | 1 |
| Armstrong, EJ | 1 |
| Waldo, SW | 1 |
| Laird, JR | 1 |
| Amsterdam, EA | 1 |
| Hasegawa, T | 1 |
| Elder, SJ | 1 |
| Bragg-Gresham, JL | 1 |
| Pisoni, RL | 1 |
| Yamazaki, S | 1 |
| Akizawa, T | 1 |
| Jadoul, M | 1 |
| Hugh, RC | 1 |
| Port, FK | 1 |
| Evans, M | 1 |
| Fored, CM | 2 |
| Bellocco, R | 1 |
| Fitzmaurice, G | 1 |
| Fryzek, JP | 2 |
| McLaughlin, JK | 2 |
| Nyrén, O | 2 |
| Elinder, CG | 2 |
| Irish, A | 1 |
| Dogra, G | 1 |
| Mori, T | 1 |
| Beller, E | 1 |
| Kerr, P | 1 |
| Rosman, J | 1 |
| Starfield, M | 1 |
| Polkinghorne, K | 1 |
| Tseng, GY | 2 |
| Lin, HJ | 2 |
| Kittisupamongkol, W | 1 |
| Sciahbasi, A | 1 |
| Arcieri, R | 1 |
| Quarto, M | 1 |
| Pendenza, G | 1 |
| Lanzillo, C | 1 |
| Summaria, F | 1 |
| Romagnoli, E | 1 |
| Commisso, C | 1 |
| Penco, M | 1 |
| Lioy, E | 1 |
| Mesquita, Mdo C | 1 |
| Sol, EB | 1 |
| Malarme, M | 1 |
| Noubouossie, D | 1 |
| Demulder, AC | 1 |
| Mousa, SA | 1 |
| Jeske, WP | 1 |
| Fareed, J | 1 |
| Ponikowski, P | 1 |
| Ronco, C | 1 |
| Anker, SD | 1 |
| Kuo, HW | 1 |
| Tsai, SS | 1 |
| Tiao, MM | 1 |
| Liu, YC | 1 |
| Lee, IM | 1 |
| Yang, CY | 1 |
| Geara, AS | 1 |
| Azzi, N | 1 |
| Bassil, C | 1 |
| Naroienejad, M | 1 |
| Saedi, D | 1 |
| Rezvani, A | 1 |
| Kilickesmez, KO | 2 |
| Kocas, C | 2 |
| Okcun, B | 2 |
| Abaci, O | 2 |
| Kaya, A | 1 |
| Arat, A | 1 |
| Gorcin, B | 2 |
| Gurmen, T | 2 |
| Pirker, S | 1 |
| Baumgartner, C | 1 |
| Esfandiar, N | 1 |
| Otukesh, H | 1 |
| Sharifian, M | 1 |
| Hoseini, R | 1 |
| Blann, AD | 1 |
| Kuzniatsova, N | 1 |
| Velu, S | 1 |
| Lip, GY | 2 |
| Olesen, JB | 1 |
| Kamper, AL | 1 |
| Hommel, K | 1 |
| Køber, L | 1 |
| Lane, DA | 1 |
| Lindhardsen, J | 1 |
| Gislason, GH | 1 |
| Torp-Pedersen, C | 1 |
| Habich, S | 1 |
| Hamidian Jahromi, A | 1 |
| Tomaszuk-Kazberuk, A | 1 |
| Kozuch, M | 1 |
| Malyszko, J | 1 |
| Bachorzewska-Gajewska, H | 1 |
| Dobrzycki, S | 1 |
| Musial, WJ | 1 |
| McCullough, PA | 1 |
| Sandberg, KR | 1 |
| Borzak, S | 1 |
| Hudson, MP | 1 |
| Garg, M | 1 |
| Manley, HJ | 1 |
| Shpitz, B | 1 |
| Plotkin, E | 1 |
| Spindel, Z | 1 |
| Buklan, G | 1 |
| Klein, E | 1 |
| Bernheim, J | 1 |
| Korzets, Z | 1 |
| Martínez, JG | 1 |
| Saus, C | 1 |
| Morey, A | 1 |
| Alarcón, A | 1 |
| Saran, R | 1 |
| Dykstra, DM | 1 |
| Wolfe, RA | 1 |
| Gillespie, B | 1 |
| Held, PJ | 1 |
| Young, EW | 1 |
| Panichi, V | 1 |
| Taccola, D | 1 |
| Migliori, M | 1 |
| Consani, C | 1 |
| Giovannini, L | 1 |
| Tetta, C | 1 |
| Ng, HJ | 1 |
| Koh, LP | 1 |
| Lee, LH | 1 |
| Obialo, CI | 1 |
| Conner, AC | 1 |
| Lebon, LF | 1 |
| Trespalacios, FC | 1 |
| Taylor, AJ | 1 |
| Agodoa, LY | 1 |
| Bakris, GL | 2 |
| Abbott, KC | 1 |
| Berger, AK | 1 |
| Duval, S | 1 |
| Krumholz, HM | 1 |
| Conti, CR | 1 |
| Kaufman, JS | 1 |
| O'Connor, TZ | 1 |
| Zhang, JH | 1 |
| Cronin, RE | 1 |
| Fiore, LD | 1 |
| Ganz, MB | 1 |
| Goldfarb, DS | 1 |
| Peduzzi, PN | 1 |
| Rabelink, TJ | 1 |
| Chua, DY | 1 |
| McAlister, FA | 2 |
| Ezekowitz, J | 2 |
| Tonelli, M | 2 |
| Armstrong, PW | 1 |
| Humphries, KH | 1 |
| Norris, CM | 1 |
| Ghali, WA | 1 |
| Knudtson, ML | 1 |
| Yusuff, KB | 1 |
| Balogun, OB | 1 |
| Krause, MW | 1 |
| Massing, M | 1 |
| Kshirsagar, A | 1 |
| Rosamond, W | 1 |
| Simpson, RJ | 1 |
| Sonson, JM | 1 |
| Lum, JJ | 1 |
| Madison, JR | 1 |
| Seto, TB | 1 |
| Spies, C | 1 |
| Ibáñez, L | 1 |
| Morlans, M | 1 |
| Vidal, X | 1 |
| Martínez, MJ | 1 |
| Laporte, JR | 1 |
| Keough-Ryan, TM | 1 |
| Kiberd, BA | 2 |
| Dipchand, CS | 1 |
| Cox, JL | 1 |
| Rose, CL | 1 |
| Thompson, KJ | 1 |
| Clase, CM | 1 |
| Woodside, DB | 1 |
| Colton, P | 1 |
| Staab, R | 1 |
| Schreiber, M | 1 |
| Sutandar-Pinnock, K | 1 |
| Poynter, B | 1 |
| Sacevich, T | 1 |
| Sirvent, AE | 1 |
| Fernández, I | 1 |
| Enríquez, R | 1 |
| Alvarez, JG | 1 |
| Santos Calle, F | 1 |
| Samper, J | 1 |
| Arenas, MD | 1 |
| Reyes, A | 1 |
| Kinduris, S | 1 |
| Vaisvila, T | 1 |
| Petronyte, J | 1 |
| Budrikis, A | 1 |
| Rho, M | 1 |
| Renda, J | 1 |
| Jochum, E | 1 |
| Janssen, U | 1 |
| Tessone, A | 1 |
| Gottlieb, S | 1 |
| Barbash, IM | 1 |
| Garty, M | 1 |
| Porath, A | 1 |
| Tenenbaum, A | 1 |
| Hod, H | 1 |
| Boyko, V | 1 |
| Mandelzweig, L | 1 |
| Behar, S | 1 |
| Leor, J | 1 |
| Wittmann, I | 2 |
| Molnár, GA | 1 |
| Wagner, L | 1 |
| Köszegi, T | 1 |
| Wagner, Z | 1 |
| Laczy, B | 1 |
| Tamaskó, M | 1 |
| Markó, L | 1 |
| Mohás, M | 1 |
| Nagy, J | 2 |
| Goldstein, SL | 1 |
| Leung, JC | 1 |
| Silverstein, DM | 1 |
| Cubbon, RM | 1 |
| Gale, CP | 1 |
| Rajwani, A | 1 |
| Abbas, A | 1 |
| Morrell, C | 1 |
| Das, R | 1 |
| Barth, JH | 1 |
| Grant, PJ | 1 |
| Kearney, MT | 1 |
| Hall, AS | 1 |
| Holden, RM | 1 |
| Harman, GJ | 1 |
| Wang, M | 1 |
| Holland, D | 1 |
| Day, AG | 1 |
| Di Renzo, L | 1 |
| Noce, A | 1 |
| De Angelis, S | 1 |
| Miani, N | 1 |
| Di Daniele, N | 1 |
| Tozzo, C | 1 |
| De Lorenzo, A | 1 |
| Yee, J | 1 |
| Marcos Vidal, JM | 1 |
| Baticón Escudero, PM | 1 |
| Higuera Miguelez, E | 1 |
| Fiz Matías, J | 1 |
| Seedat, YK | 1 |
| MacSearraigh, ET | 1 |
| Davì, G | 1 |
| Orlandi, M | 1 |
| Picone, F | 1 |
| Galione, G | 1 |
| Meringolo, C | 1 |
| Mazzola, A | 1 |
| Tomasi, V | 1 |
| Capodicasa, G | 1 |
| Strano, A | 1 |
| Bernardi, P | 2 |
| Bastagli, L | 2 |
| Pecoraro, F | 1 |
| Vitolo, A | 1 |
| Minelli, C | 2 |
| Cavazza, M | 2 |
| Adani, C | 1 |
| Willoughby, ML | 1 |
| Plotz, PH | 1 |
| Kimberly, RP | 1 |
| Kleinknecht, D | 1 |
| Bissé, E | 1 |
| Huaman-Guillen, P | 1 |
| Wieland, H | 1 |
| Kooistra, MP | 1 |
| van Es, A | 1 |
| Marx, JJ | 1 |
| Hertsig, ML | 1 |
| Struyvenberg, A | 1 |
| Osterziel, KJ | 1 |
| Nagel, F | 1 |
| Dietz, R | 1 |
| Perneger, TV | 1 |
| Whelton, PK | 1 |
| Klag, MJ | 1 |
| Duclos, J | 1 |
| D'Agati, V | 1 |
| Windus, DW | 1 |
| Santoro, SA | 1 |
| Atkinson, R | 1 |
| Royal, HD | 1 |
| Schwarz, A | 1 |
| Hörl, WH | 1 |
| Bacon, NC | 1 |
| Gascón Ramón, G | 1 |
| Bertomeu i Blanch, F | 1 |
| Baño Aracil, M | 1 |
| Madrigal, JA | 1 |
| Gault, MH | 3 |
| Barrett, BJ | 1 |
| Bach, PH | 1 |
| Berndt, WO | 1 |
| Delzell, E | 2 |
| Dubach, U | 1 |
| Finn, WF | 1 |
| Fox, JM | 2 |
| Hess, R | 1 |
| Michielsen, P | 2 |
| Sandler, DP | 1 |
| Trump, B | 1 |
| Williams, G | 1 |
| Bahner, U | 1 |
| Heidland, A | 1 |
| Lornoy, W | 1 |
| Becaus, I | 1 |
| Billiouw, JM | 1 |
| Sierens, L | 1 |
| Taher, A | 1 |
| Ammash, Z | 1 |
| Dabajah, B | 1 |
| Nasrallah, A | 1 |
| Mourad, FH | 1 |
| Feinstein, AR | 1 |
| Heinemann, LA | 1 |
| Curhan, GC | 1 |
| Deschepper, PJ | 1 |
| Graf, H | 1 |
| Luft, FC | 1 |
| Mihatsch, MJ | 1 |
| Suissa, S | 1 |
| Van Der Woude, F | 1 |
| Willich, S | 1 |
| Foggensteiner, L | 1 |
| Mulroy, S | 1 |
| Firth, J | 1 |
| Pintér, I | 1 |
| Mátyus, J | 1 |
| Czégány, Z | 1 |
| Harsányi, J | 1 |
| Homoki, M | 1 |
| Kassai, M | 1 |
| Kiss, E | 1 |
| Kiss, I | 1 |
| Ladányi, E | 1 |
| Lócsey, L | 1 |
| Major, L | 1 |
| Misz, M | 1 |
| Nagy, L | 1 |
| Polner, K | 1 |
| Rédl, J | 1 |
| Solt, I | 1 |
| Tichy, B | 1 |
| Török, M | 1 |
| Varga, G | 1 |
| Wagner, G | 1 |
| Wórum, I | 1 |
| Zsoldos, B | 1 |
| Pótó, L | 1 |
| Ejerblad, E | 1 |
| Lindblad, P | 1 |
| Dickman, PW | 1 |
| Signorello, LB | 1 |
| Lipworth, L | 1 |
| Blot, WJ | 1 |
| Zack, MM | 1 |
| Crofford, LJ | 1 |
| Thurlow, W | 1 |
| Doherty, CC | 1 |
| McGeown, MG | 1 |
| Remuzzi, G | 3 |
| Mingardi, G | 1 |
| Mecca, G | 2 |
| Donati, MB | 1 |
| de Gaetano, G | 1 |
| Burry, A | 1 |
| Cross, R | 1 |
| Axelsen, R | 1 |
| Pütter, J | 4 |
| Berg, KJ | 1 |
| Langman, MJ | 1 |
| Stewart, JH | 2 |
| Gallery, ED | 1 |
| McCarthy, SW | 1 |
| Storey, BG | 1 |
| Roberts, BA | 1 |
| Gallery, E | 1 |
| Mahony, JF | 1 |
| Goldberger, LE | 1 |
| Talner, LB | 1 |
| Arger, PH | 1 |
| Bluth, EI | 1 |
| Murray, T | 1 |
| Goldberg, M | 1 |
| Daneels, R | 2 |
| Loew, D | 1 |
| Manske, CL | 1 |
| Wang, Y | 1 |
| Rector, T | 1 |
| Wilson, RF | 1 |
| White, CW | 1 |
| Hall, AV | 1 |
| Clark, WF | 1 |
| Parbtani, A | 1 |
| Gordge, MP | 1 |
| Rylance, PB | 1 |
| Neild, GH | 1 |
| Taylor, JE | 1 |
| Henderson, IS | 1 |
| Stewart, WK | 1 |
| Belch, JJ | 1 |
| McCarthy, L | 1 |
| Kotylo, P | 1 |
| Lister, K | 1 |
| Matsuo, T | 1 |
| Yamada, T | 1 |
| Chikahira, Y | 1 |
| Kadowaki, S | 1 |
| Livio, M | 1 |
| Benigni, A | 1 |
| Viganò, G | 2 |
| van Heyningen, R | 1 |
| Harding, JJ | 1 |
| Ehrich, JH | 1 |
| Wurster, U | 1 |
| Lütge, M | 1 |
| Doehring, E | 1 |
| Oemar, B | 1 |
| Gogoll, L | 1 |
| Bentsen, P | 1 |
| Hochrein, H | 1 |
| Ghezzi, F | 1 |
| Grimaldi, R | 1 |
| Fontana, F | 1 |
| Clo', C | 1 |
| Ventura, C | 1 |
| Capelli, M | 1 |
| Nath, KA | 1 |
| Gaspari, F | 1 |
| Locatelli, M | 1 |
| Buckalew, VM | 1 |
| Schey, HM | 1 |
| Laxer, RM | 1 |
| Silverman, ED | 1 |
| Balfe, JW | 1 |
| Poucell, S | 1 |
| Baumal, R | 1 |
| David, DS | 1 |
| Steere, AC | 1 |
| Pi-Sunyer, XF | 1 |
| Sakai, S | 1 |
| Clark, SB | 1 |
| Rabiner, SF | 1 |
| Vonend, E | 1 |
| Böttcher, D | 1 |
| Knödler, U | 1 |
| Heinze, V | 1 |
| Wilson, DR | 1 |
| Harrison, JF | 1 |
| Parker, RW | 1 |
| De Silva, KL | 1 |
| Frohlich, J | 1 |
| Price, GE | 1 |
| Campbell, DJ | 1 |
| Bergentz, SE | 1 |
| Powell, HR | 1 |
| Ekert, H | 1 |
| Postlethwaite, AE | 1 |
| Gutman, RA | 1 |
| Kelley, WN | 1 |
| Gregg, S | 1 |
| Kwaan, HC | 1 |
| Colwell, JA | 1 |
| Cruz, S | 1 |
| Suwanwela, N | 1 |
| Dobbie, JG | 1 |
| Shahidi, NT | 1 |
| Gabe, A | 1 |
| McMillan, JM | 1 |
| Lawson, DH | 1 |
| Paton, AM | 1 |
| Linton, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan - a Double Blind Randomised Study[NCT00791830] | Phase 3 | 82 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
| Vitamin K Supplementation to Improve INR Stability in Patients on Hemodialysis Taking Warfarin for Atrial Fibrillation[NCT02324686] | Phase 2 | 3 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| REACTIC-TAVI Trial: Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation. A Pilot Study.[NCT04331145] | Phase 4 | 40 participants (Actual) | Interventional | 2020-06-23 | Completed | ||
| RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial[NCT02942407] | Phase 4 | 154 participants (Actual) | Interventional | 2016-12-31 | Completed | ||
| Registry of Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis[NCT03446794] | 300 participants (Actual) | Observational [Patient Registry] | 2018-03-14 | Completed | |||
| Evaluation of Platelet Aggregation and Adenosine Levels in Patients With Coronary Artery Disease and Chronic Kidney Dysfunction Taking Dual Antiplatelet Therapy With Aspirin and Clopidogrel or Ticagrelor[NCT03039205] | Phase 2 | 90 participants (Actual) | Interventional | 2017-11-07 | Completed | ||
| Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients[NCT00651521] | 1,000 participants (Actual) | Observational | 2009-04-30 | Active, not recruiting | |||
| Effects of Low and High Doses of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes and Possible Influence of the Glycemic Control.[NCT01397513] | Phase 4 | 48 participants (Actual) | Interventional | 2006-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluate the pharmacokinetics of apixaban in ESRD NVAF patients on hemodialysis. The measurement was done from 0-12 hours after the dose was given on Day 1. (NCT02942407)
Timeframe: 0-12 hours post-dose
| Intervention | ng/mL (Geometric Mean) |
|---|---|
| Apixaban 2.5 mg | 59.7 |
| Apixaban 5 mg | 97.9 |
Evaluate the pharmacokinetics of apixaban in ESRD NVAF patients on hemodialysis. The measurement was done from 0-12 hours after the dose was given on Day 1. (NCT02942407)
Timeframe: 0-12 hours post-dose
| Intervention | ng/mL (Geometric Mean) |
|---|---|
| Apixaban 2.5 mg | 28.2 |
| Apixaban 5mg | 49.7 |
Evaluate the pharmacokinetics of apixaban in ESRD NVAF patients on hemodialysis. The measurement was done from 0 to 12 hours after dose was given on Day 1. (NCT02942407)
Timeframe: 0-12 hours post-dose
| Intervention | ng*h/mL (Geometric Mean) |
|---|---|
| Apixaban 2.5 mg | 507 |
| Apixaban 5mg | 868 |
"Assess the safety of apixaban versus warfarin regarding ISTH major bleeding or clinically relevant non-major bleeding events in patients with NVAF (nonvalvular atrial fibrillation) and ESRD (end-stage renal disease) on hemodialysis.~Major bleeding event is defined as:Acute clinically overt bleeding (including access site related bleeding) accompanied by 1 or more of the following: Decrease in Hgb of 2g/dL or more with overt bleeding; Transfusion of 2 or more units of packed RBCs in the setting of an overt bleeding event; Bleeding within a critical site. Hemorrhagic stroke (primary or infarction with hemorrhagic conversion) were classified as major bleeds.~Non-major bleeding event is defined as: Acute or sub-acute clinically overt bleeding (including access site related bleeding) that does not meet criteria for major bleeding & results in Hospital admission for bleeding, physician guided medical or surgical treatment for bleeding, or change in antithrombotic therapy" (NCT02942407)
Timeframe: Randomization up to Month 15/Final Visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Apixaban | 21 |
| Warfarin | 16 |
Evaluate mortality rates for those participants randomized to warfarin and apixaban in patients with NVAF and ESRD on hemodialysis (NCT02942407)
Timeframe: Randomization up to Month 15/Final Visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Apixaban | 21 |
| Warfarin | 13 |
"Adjudcated stroke defined as a new, non-traumatic episode of focal or global neurological dysfunction of sudden onset caused by central nervous system (CNS) vascular injury as a result of hemorrhage or infarction and not due to a readily identifiable non-vascular cause (i.e. brain tumor). CNS includes brain, spinal cord and retina. The required duration of the deficit is ≥ 24 hours.~Events with neurologic deficit lasting for < 24 hours and an imaging modality showing evidence of an acute stroke will be counted as stroke as well.~A retinal ischemic event (embolism, infarction) will be considered a stroke" (NCT02942407)
Timeframe: Randomization up to Month 15/Final Visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Apixaban | 2 |
| Warfarin | 2 |
Number of participants experiencing adjudicated stroke or systemic embolism. (NCT02942407)
Timeframe: Randomization up to Month 15/Final Visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Apixaban | 2 |
| Warfarin | 2 |
"Evaluate those experiencing stroke, systemic embolism, ISTH major bleeding, or all-cause mortality for those randomized to warfarin and apixaban in patients with NVAF and ESRD on hemodialysis~Definitions of stroke and systemic embolism are provided under the measurement description of the secondary outcomes for each individual event. Definition of major bleed is provided in outcome measurement description of the primary outcome measure." (NCT02942407)
Timeframe: Randomization up to Month 15/Final Visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Apixaban | 27 |
| Warfarin | 29 |
"Adjudicated diagnosis of systemic arterial embolism (Non-pulmonary, non-cranial events) will require a positive clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries), which is supported by evidence of embolism/thrombosis from surgical specimens, autopsy, angiography, vascular imaging, or other objective testing.~Clinical presentation would include:~Abrupt development of pain, absent pulses, pallor, and/or paresis in an extremity (at least an entire digit) without previous severe claudication or findings of severe peripheral vascular disease.~Renal embolism will be diagnosed when sudden flank pain or a change in renal laboratory findings occurred.~Abdominal vascular/visceral embolism was considered definite if acute abdominal symptoms or referred symptoms developed along with a change in abdominal examination or appropriate laboratory values." (NCT02942407)
Timeframe: Randomization up to Month 15/Final Visit
| Intervention | Participants (Count of Participants) |
|---|---|
| Apixaban | 0 |
| Warfarin | 0 |
Evaluate days between time from initiation to discontinuation of randomized therapy. (NCT02942407)
Timeframe: Randomization up to Month 15/Final Visit
| Intervention | Days (Mean) |
|---|---|
| Apixaban | 304.4 |
| Warfarin | 279.6 |
24 reviews available for aspirin and Chronic Kidney Failure
| Article | Year |
|---|---|
Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention.
Topics: Aspirin; Biological Availability; Clopidogrel; Drug Interactions; Drug Resistance; Humans; Ischemic | 2021 |
Bleeding after endoscopic submucosal dissection: Risk factors and preventive methods.
Topics: Anticoagulants; Aspirin; Comorbidity; Endoscopic Mucosal Resection; Endoscopy, Gastrointestinal; Gas | 2016 |
Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials, Phase III as Topi | 2010 |
The role of chronic inflammation in cardiovascular mortality of uremic patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Cardiovascular Diseases; Human | 2003 |
Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?
Topics: Adult; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Dietary Supplements; Folic Acid; H | 2004 |
Diabetes and chronic kidney disease: tragedy and challenge.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Blood Glucose; Calcium Channel Blocke | 2004 |
[Congenital and acquired thrombocyte function disorders].
Topics: Aspirin; Blood Platelet Disorders; Dipyridamole; Fibrin Fibrinogen Degradation Products; Heart Defec | 1980 |
Acute effects of aspirin and acetaminophen on renal function.
Topics: Acetaminophen; Aspirin; Humans; Indomethacin; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Lupu | 1981 |
Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Caffeine; Humans; Kidney Failure, C | 1995 |
Does aspirin cause acute or chronic renal failure in experimental animals and in humans?
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Models, Anim | 1996 |
[Intervention in risk factors and protection of target organs].
Topics: Alcohol Drinking; Aspirin; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Est | 1997 |
Analgesic nephropathy.
Topics: Acetaminophen; Analgesics; Aspirin; Caffeine; Canada; Drug Combinations; Drug Synergism; Humans; Kid | 1998 |
A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Caffeine; | 1998 |
Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review.
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Aspirin; Bone Marrow Cells; Coronary Disease; Female; Gas | 2000 |
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; | 2000 |
Management of diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Diseases; Diabetic Nephropathies; | 2001 |
Cardiovascular risk reduction in renal transplantation. Strategies for success.
Topics: Arteriosclerosis; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Comorbidity; Cost-Benefit | 2002 |
Analgesic nephropathy and the renal concentrating mechanism.
Topics: Aging; Amyloidosis; Analgesics; Anemia, Sickle Cell; Animals; Aspirin; Calcinosis; Dehydration; Diab | 1977 |
[Pharmacokinetics of acetylsalicylic acid].
Topics: Aspirin; Biological Availability; Female; Humans; Hydrolysis; Kidney Failure, Chronic; Kinetics; Mil | 1976 |
Analgesic abuse syndrome: a frequently overlooked cause of reversible renal failure.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Caffeine; Diagnosis, Differential; Dr | 1975 |
Analgesic abuse nephropathy.
Topics: Analgesics; Aspirin; Calcinosis; Female; Humans; Kidney Failure, Chronic; Kidney Papillary Necrosis; | 1976 |
Platelets, antiplatelet therapy, and diabetic nephropathy.
Topics: Aspirin; Diabetic Nephropathies; Dipyridamole; Humans; Kidney Failure, Chronic; Platelet Aggregation | 1988 |
Bleeding in uremia.
Topics: Adenine Nucleotides; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Capillary Fragi | 1972 |
Rheumatoid arthritis in childhood.
Topics: Adolescent; Amyloidosis; Arthritis, Juvenile; Aspirin; Child; Child, Preschool; Female; Fever; Gold; | 1971 |
16 trials available for aspirin and Chronic Kidney Failure
| Article | Year |
|---|---|
High-sensitivity Troponin T in hemodialysis patients: a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcome.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bi | 2020 |
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriovenous Fistula; Aspirin; Double-Blind Method; Drug T | 2019 |
Nurse practitioner care improves renal outcome in patients with CKD.
Topics: Aged; Ambulatory Care Facilities; Antihypertensive Agents; Aspirin; Biomarkers; Cholesterol, LDL; Cr | 2014 |
Platelet reactivity after receiving clopidogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study.
Topics: Adenosine; Adult; Aspirin; Clopidogrel; Cross-Over Studies; Drug Therapy, Combination; Female; Human | 2015 |
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Central Venous Catheters; Docosahexaenoic Acids; Double-Blin | 2015 |
Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.
Topics: Administration, Oral; Adult; Arteriovenous Shunt, Surgical; Aspirin; Constriction, Pathologic; Dieta | 2017 |
Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arteriovenous Shunt, Surgical; Aspirin; Clinical Pro | 2009 |
Protective effect of heparin and aspirin against vascular thrombosis in pediatric kidney transplants.
Topics: Anticoagulants; Aspirin; Child; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; He | 2012 |
Renal function and aspirin resistance in patients with coronary artery disease.
Topics: Aspirin; Coronary Artery Disease; Drug Resistance; Female; Glomerular Filtration Rate; Humans; Kidne | 2012 |
Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.
Topics: Aged; Aspirin; Catheters, Indwelling; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; F | 2003 |
Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis.
Topics: Aged; Anemia; Aspirin; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Erythropoietin; Female; H | 2007 |
Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Cytokines; Humans; Inflammation | 2006 |
Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin.
Topics: Adult; Anemia; Aspirin; Cross-Over Studies; Double-Blind Method; Erythropoietin; Female; Hematocrit; | 1994 |
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Flow Velocity; Blood Pressure; Captop | 1994 |
Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure.
Topics: Adult; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Calcium Channel Blockers; Coronary | 1992 |
Erythropoietin and spontaneous platelet aggregation in haemodialysis patients.
Topics: Anemia; Aspirin; Blood Coagulation; Dipyridamole; Erythropoietin; Humans; In Vitro Techniques; Kidne | 1991 |
120 other studies available for aspirin and Chronic Kidney Failure
| Article | Year |
|---|---|
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.
Topics: Adult; Aspirin; Bisoprolol; Conservative Treatment; Furosemide; Ghana; Humans; Irbesartan; Kidney Fa | 2022 |
Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Case-Control Studies; Clopidogrel; Diabete | 2021 |
Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease. Associations with laboratory findings, comorbidities, and medications.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aspirin; Calcium Channel Blockers; Cardiovascu | 2018 |
Effects of aspirin resistance and mean platelet volume on vascular access failure in hemodialysis patients.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Vessel Prosthesis Implantation; Drug Resistance; | 2019 |
High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis.
Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug Substitution; Female; Hum | 2019 |
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dip | 2019 |
Heterochronic spontaneous rupture of bilateral renal cell carcinomas in a hemodialysis patient.
Topics: Anemia; Aspirin; Blood Transfusion; Carcinoma, Renal Cell; Glomerulonephritis; Hematuria; Humans; Ki | 2013 |
No increase in risk of microscopic hematuria with aspirin use by asymptomatic healthy people.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; | 2013 |
Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.
Topics: Aged; Anticoagulants; Aspirin; Cohort Studies; Female; Fibrinolytic Agents; Gastrointestinal Hemorrh | 2013 |
Aspirin resistance in patients undergoing hemodialysis and effect of hemodialysis on aspirin resistance.
Topics: Adult; Aged; Aspirin; Drug Resistance; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; P | 2015 |
Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study.
Topics: Aged; Aspirin; Biomarkers; Chi-Square Distribution; Diabetes Complications; Female; Fibrinolytic Age | 2013 |
Thrombosis of the great cerebral vein in a hemodialysis patient.
Topics: Adult; Aspirin; Cerebral Veins; Female; Fibrinolytic Agents; Humans; Intracranial Pressure; Kidney F | 2014 |
Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Factor Xa Inhibitors; Fondaparinux; | 2013 |
Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study.
Topics: Aspirin; Blood Loss, Surgical; Case-Control Studies; Clopidogrel; Dose-Response Relationship, Drug; | 2014 |
Haemodialysis impairs clopidogrel but not aspirin responsiveness in patients with end-stage renal disease. Results of a pilot study.
Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; Follow-Up Studies; Hum | 2014 |
Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate | 2014 |
Acetylsalicylic acid mitigates erythropoietin-associated blood pressure increase in nonuremic rats.
Topics: Anemia; Animals; Aspirin; Blood Pressure; Disease Models, Animal; Drug Monitoring; Erythropoietin; H | 2015 |
Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Female; H | 2014 |
Successful Management of Recurrent Colon Ulcer in Hemodialysis Patient after Conversion to Peritoneal Dialysis.
Topics: Aspirin; Colon; Colonic Diseases; Colonoscopy; Drug Therapy, Combination; Gastrointestinal Hemorrhag | 2015 |
Chronic Kidney Disease and Health Status Outcomes Following Acute Myocardial Infarction.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Case-Control Studies; Coho | 2016 |
Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Arabs; Aspirin; Calcium Carbonate; Comorbidity; Diabetes | 2016 |
Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.
Topics: Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Drug Ther | 2017 |
Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
Topics: Adrenergic beta-Antagonists; Aged; Aspirin; California; Coronary Artery Disease; Diabetes Mellitus; | 2017 |
Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Australia; Europe; Female; Gastrointestinal Hemorrhage | 2008 |
Acetaminophen, aspirin and progression of advanced chronic kidney disease.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Aspirin; Cohort Studies; Female; Follow-Up Stu | 2009 |
Factors aside from Helicobacter pylori play an important role in the occurrence of peptic ulcer in dialysis patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter pylori; Humans; Kidney Failure, Chron | 2009 |
Clopidogrel in ESRD patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Hemorrhage; Humans; Kidney Failure, Chronic; Platelet | 2009 |
Impact of chronic aspirin and statin therapy on presentation of patients with acute myocardial infarction and impaired renal function.
Topics: Aged; Anticholesteremic Agents; Aspirin; Confidence Intervals; Female; Glomerular Filtration Rate; H | 2010 |
Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis.
Topics: Aged; Aspirin; Blood Cell Count; Blood Chemical Analysis; Blood Transfusion; Drug Resistance; Erythr | 2009 |
Cardiorenal syndromes--recommendations from clinical practice guidelines: the cardiologist's view.
Topics: Acute Disease; Acute Kidney Injury; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhib | 2010 |
Analgesic use and the risk for progression of chronic kidney disease.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin | 2010 |
Aspirin resistance in hemodialysis patients.
Topics: Aspirin; Diabetes Complications; Drug Resistance; Humans; Kidney Failure, Chronic; Platelet Aggregat | 2012 |
Prevalence of central vein stenosis following catheterization in patients with end-stage renal disease.
Topics: Adult; Aged; Anticoagulants; Aspirin; Catheterization, Central Venous; Constriction, Pathologic; Cro | 2010 |
Laboratory signs of aspirin response in haemodialysis patients.
Topics: Aged; Aspirin; Case-Control Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pla | 2011 |
Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil.
Topics: Aged, 80 and over; Anticonvulsants; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1 | 2011 |
Follow-up of aspirin-resistant patients with end-stage kidney disease.
Topics: Aged; Angina, Unstable; Area Under Curve; Aspirin; Cause of Death; Cohort Studies; Drug Resistance; | 2013 |
Stroke and bleeding in atrial fibrillation with chronic kidney disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Kidney Failure, | 2012 |
Stroke and bleeding in atrial fibrillation with chronic kidney disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Kidney Failure, | 2012 |
Stroke and bleeding in atrial fibrillation with chronic kidney disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Kidney Failure, | 2012 |
Stroke and bleeding in atrial fibrillation with chronic kidney disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Kidney Failure, | 2012 |
[Risks in atrial fibrillation and simultaneous renal failure].
Topics: Aspirin; Atrial Fibrillation; Cerebral Infarction; Comorbidity; Fibrinolytic Agents; Humans; Kidney | 2012 |
Re: Protective effect of heparin and aspirin against vascular thrombosis in pediatric kidney transplants.
Topics: Anticoagulants; Aspirin; Female; Heparin; Humans; Kidney Failure, Chronic; Kidney Transplantation; M | 2012 |
Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting E | 2013 |
Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Dis | 2002 |
Should aspirin therapy be withheld before insertion and/or removal of a permanent peritoneal dialysis catheter?
Topics: Aged; Aspirin; Case-Control Studies; Catheters, Indwelling; Female; Humans; Kidney Failure, Chronic; | 2002 |
[Crohn's disease and renal amyloidosis. Acute renal failure].
Topics: Acetaminophen; Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Amyloidosis; Analgesics, Non-Nar | 2002 |
Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticoagul | 2002 |
Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin.
Topics: Adult; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Factor VIIa; Female; Hemorrhage; Hepa | 2003 |
Maintaining patency of tunneled hemodialysis catheters--efficacy of aspirin compared to warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Catheters, Indwelling; Equipment Failure; F | 2003 |
Heart failure as a cause for hospitalization in chronic dialysis patients.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular | 2003 |
Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; A | 2003 |
Management of patients with acute myocardial infarction and end-stage renal disease.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Humans; Kidney Failu | 2003 |
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspi | 2004 |
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspi | 2004 |
Pattern of drug utilization among hypertensives in a Nigerian teaching hospital.
Topics: Aspirin; Cross-Sectional Studies; Diabetes Complications; Diuretics; Drug Combinations; Drug Interac | 2005 |
Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspi | 2004 |
Gender differences in therapy for patients admitted for unstable angina and myocardial infarction with underlying chronic kidney disease.
Topics: Acute Disease; Aged; Aged, 80 and over; Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; | 2004 |
Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease.
Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Fem | 2005 |
Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anemia; Angina, Unstable; Angiotensin-Converting Enzyme In | 2005 |
Weight restoration in a patient with anorexia nervosa on dialysis.
Topics: Adult; Anorexia Nervosa; Aspirin; Barbiturates; Body Mass Index; Body Weight; Caffeine; Combined Mod | 2005 |
[Hypersensitivity reaction to systemic corticosteroids in a hemodialysis patients].
Topics: Adrenal Cortex Hormones; Adult; Anaphylaxis; Aspirin; Asthma; Bronchial Spasm; Desensitization, Immu | 2006 |
[Bleeding after cardiac surgery: risk factors, frequency, and outcomes].
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Diabetes Mellitus, | 2006 |
Pica presenting as metabolic alkalosis and seizure in a dialysis patient.
Topics: Adult; Alkalosis; Aspirin; Citrates; Drug Combinations; Female; Humans; Iron Deficiencies; Kidney Fa | 2006 |
[Chronic interstitial nephritis in an 18-year-old due to intake of a compound analgesic].
Topics: Acetaminophen; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Caffeine; Creat | 2006 |
Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspi | 2007 |
Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cohort Studies; Di | 2008 |
Major bleeding in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Drug Therapy, Combination; Fema | 2008 |
Anti-inflammatory effects of combined treatment with acetyl salicylic acid and atorvastatin in haemodialysis patients affected by Normal Weight Obese syndrome.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastati | 2008 |
Chronic kidney disease--a disease domain complex.
Topics: Aged; Alendronate; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Asp | 2008 |
[Severe bleeding from the radial artery after puncture for blood gas analysis in a patient with kidney failure receiving antiplatelet therapy].
Topics: Aged, 80 and over; Aspirin; Blood Gas Analysis; Combined Modality Therapy; Deamino Arginine Vasopres | 2008 |
Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; Dyspepsia | 2008 |
The abuse of analgesics leading to nephropathy in South Africa.
Topics: Acetaminophen; Analgesics; Aspirin; Female; Humans; Kidney Failure, Chronic; Male; Phenacetin | 1984 |
Plasmatic TXB2 and 6-keto-PGF1 alpha levels during charcoal hemoperfusion in chronic renal failure patients.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Charcoal; Hemoperfusion; Heparin; Humans; Kidney Failu | 1983 |
[Effect, on renal function, of a product rich in polyunsaturated fatty acids: results obtained in subjects with chronic renal failure caused by nephroangiosclerosis].
Topics: Aged; Aspirin; Fatty Acids, Unsaturated; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney | 1982 |
Analgesic abuse and the kidney.
Topics: Aged; Analgesics; Aspirin; Caffeine; Codeine; Drug Combinations; Humans; Kidney; Kidney Diseases; Ki | 1980 |
Chromatographic evaluation of minor hemoglobins: clinical significance of hemoglobin A1d, comparison with hemoglobin A1c, and possible interferences.
Topics: Aspirin; Chromatography, Affinity; Chromatography, High Pressure Liquid; Diabetes Mellitus; Erythroc | 1995 |
Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs.
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Causal | 1994 |
[Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
Topics: Adolescent; Adult; Aged; Aspirin; Chronic Disease; Clinical Protocols; Dipyridamole; Female; Glomeru | 1993 |
Effects of antiplatelet drugs on dialysis-associated platelet deposition in polytetrafluoroethylene grafts.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Vessel Prosthesis; Humans; Indium Radioisotopes; Kidne | 1997 |
[Nephrotoxicity of analgesic combination preparations].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Caffeine; Drug Combinations; Humans; Kidney Failur | 1997 |
[Comment on the contribution: "Usefulness of fixed analgesic combinations exemplified by thomapyrin"].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Caffeine; Drug Combinations; Humans; Kidney Failur | 1997 |
Hospital-acquired hyperkalaemia.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Ateno | 1997 |
[Acetylsalicylic acid in renal failure].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Disease; Dose-Response Relationship, Drug | 1998 |
Analgesic nephropathy: clinical features and pathogenesis. Original data on the incidence and prevalence in a single renal unit.
Topics: Adult; Age Factors; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin | 1998 |
[Analgesics-induced chronic renal failure in patients on dialysis therapy in Hungary].
Topics: Acetaminophen; Adult; Aged; Amphetamine; Analgesics; Aspirin; Caffeine; Codeine; Female; Humans; Hun | 2001 |
Acetaminophen, aspirin, and chronic renal failure.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bias; Cas | 2001 |
Rational use of analgesic and antiinflammatory drugs.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxyg | 2001 |
Acetaminophen, aspirin, and renal failure.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; K | 2002 |
Aspirin and renal function.
Topics: Aspirin; Humans; Kidney Failure, Chronic; Peptic Ulcer; Peptic Ulcer Hemorrhage | 1977 |
Does aspirin precipitate major gastrointestinal bleeding in patients on haemodialysis?
Topics: Aspirin; Gastrointestinal Hemorrhage; Humans; Kidney Failure, Chronic; Renal Dialysis; Risk | 1977 |
Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency.
Topics: Aged; Aspirin; Diuresis; Drug Interactions; Female; Furosemide; Glomerular Filtration Rate; Humans; | 1977 |
[Influence of genetic factors, of ulcerogenic drugs and of a sound disease on both the incidence and characteristics of peptic ulcer].
Topics: Adrenal Cortex Hormones; Aspirin; Cardiovascular Diseases; Diabetes Complications; Humans; Kidney Fa | 1976 |
Analgesic abuse and kidney disease.
Topics: Analgesics; Animals; Aspirin; Australia; Carcinoma, Transitional Cell; Female; Humans; Kidney Diseas | 1976 |
Diseases causing end-stage renal failure in New South Wales.
Topics: Acetaminophen; Adult; Analgesics; Aspirin; Australia; Caffeine; Codeine; Cystoscopy; Female; Glomeru | 1975 |
[Quantitative determination of the main metabolites of acetylsalicylic acid. 1. A method for the quantitative determination of salicylic acid and its metabolites. Studies in healthy individuals].
Topics: Adult; Aspirin; Gentisates; Glucuronates; Humans; Hydrolysis; Kidney Failure, Chronic; Methods; Sali | 1975 |
[Quantitative determination of the main metabolites of acetylsalicylic acid/2nd communication: the concentrations of salicylic acid and its metabolites in patients with renal insufficiency (author's transl)].
Topics: Adult; Aspirin; Blood Urea Nitrogen; Creatinine; Glucuronates; Humans; Kidney Failure, Chronic; Male | 1975 |
Heparin-induced thrombocytopenia in renal failure.
Topics: Adult; Aspirin; Catheterization, Central Venous; Female; Heparin; Humans; Kidney Failure, Chronic; N | 1992 |
Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Topics: Aspirin; Blood Pressure; Creatinine; Diabetic Nephropathies; Dipyridamole; Docosahexaenoic Acids; Dr | 1992 |
Plasma exchange and thrombotic thrombocytopenic purpura, the Indiana University Medical Center experience.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Plasma Excha | 1990 |
Effect of aspirin on heparin-induced thrombocytopenia (HIT) in a patient requiring hemodialysis.
Topics: Aged; Aspirin; Blood Platelets; Heparin; Humans; Immunoglobulin G; Kidney Failure, Chronic; Male; Re | 1989 |
Moderate doses of aspirin and risk of bleeding in renal failure.
Topics: Adolescent; Adult; Aged; Aspirin; Bleeding Time; Female; Hemorrhage; Hemostasis; Humans; Infusions, | 1986 |
Do aspirin-like analgesics protect against cataract? A case-control study.
Topics: Acetaminophen; Aged; Analgesics; Aspirin; Cataract; Diabetes Complications; Epidemiologic Methods; F | 1986 |
[Enzymuria and kidney diseases in childhood].
Topics: Acetylglucosaminidase; Adolescent; Aminopeptidases; Anti-Bacterial Agents; Aspirin; CD13 Antigens; C | 1986 |
[Cerebral complications in chronic acetylsalicylic acid poisoning].
Topics: Aspirin; Chronic Disease; Cognition Disorders; Coma; Combined Modality Therapy; Consciousness Disord | 1989 |
Effects of polyunsaturated fatty acids and prostaglandin synthesis on renal function.
Topics: Aspirin; Body Water; Dinoprostone; Fatty Acids, Unsaturated; Heart Failure; Humans; Injections, Intr | 1986 |
Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis.
Topics: Absorption; Adult; Aluminum Hydroxide; Antacids; Aspirin; Calcium Carbonate; Drug Administration Sch | 1988 |
Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Kidney; Kidney Diseases; Kidney Failure, C | 1986 |
Naproxen-associated renal failure in a child with arthritis and inflammatory bowel disease.
Topics: Adolescent; Arthritis, Juvenile; Aspirin; Colitis; Drug Therapy, Combination; Female; Humans; Kidney | 1987 |
Aspirin-induced hypoglycaemia in a patient on haemodialysis.
Topics: Adult; Aspirin; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemia; Kidney Failure, Chroni | 1971 |
[Qualitative chromatographic determination of the conjugates of salicylic and salicyluric acids in blood plasma and urine].
Topics: Aspirin; Chromatography, Thin Layer; Glucuronates; Glycine; Humans; Hydrolysis; Kidney Failure, Chro | 1974 |
[Changes of plasma coagulatiion and blood platelet function in patients with kidney insufficiency and their modification through homodialysis, kidney transplantation and acetylsalicylic acid].
Topics: Adult; Aspirin; Blood Coagulation; Blood Platelets; Female; Humans; Kidney Failure, Chronic; Kidney | 1974 |
Analgesic nephropathy.
Topics: Analgesics; Aspirin; Humans; Kidney Failure, Chronic; Nephritis, Interstitial; Phenacetin | 1972 |
Evidence for the nephrotoxicity of analgesics.
Topics: Analgesics; Aspirin; Caffeine; Humans; Kidney Failure, Chronic; Phenacetin; Pyelonephritis; Substanc | 1972 |
Lysozymuria and acute disorders of renal function.
Topics: Acetaminophen; Acute Disease; Aspirin; Electroshock; Glomerulonephritis; Heart Failure; Humans; Hypo | 1973 |
Problems in the laboratory diagnosis of alcaptonuria.
Topics: Alkaptonuria; Arthritis, Rheumatoid; Aspirin; Cerumen; Child, Preschool; Chromatography, Paper; Colo | 1973 |
[Proceedings: Bleeding problems due to platelet disorders (author's transl)].
Topics: Aspirin; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Humans; Kidney Failure, Chroni | 1973 |
Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome.
Topics: Aspirin; Biopsy; Child; Child, Preschool; Dipyridamole; Hemolytic-Uremic Syndrome; Hemorrhage; Hepar | 1974 |
Editorial: Analgesic nephropathy or phenacetin poisoning.
Topics: Animals; Aspirin; Humans; Kidney Failure, Chronic; Phenacetin; Proteinuria; Rats; Substance-Related | 1974 |
Salicylate-mediated increase in urate removal during hemodialysis: evidence for urate binding to protein in vivo.
Topics: Aspirin; Blood Proteins; Depression, Chemical; In Vitro Techniques; Kidney Failure, Chronic; Male; P | 1974 |
Increased platelet aggregation in diabetes mellitus.
Topics: Adenosine Diphosphate; Aspirin; Blood Chemical Analysis; Blood Proteins; Creatinine; Diabetes Mellit | 1972 |
The effect of acetylsalicylic acid, caffeine, and codeine on the excretion of phenacetin metabolites.
Topics: Acetaminophen; Aniline Compounds; Aspirin; Caffeine; Chromatography, Thin Layer; Codeine; Creatinine | 1972 |
The analgesic powder.
Topics: Abnormalities, Drug-Induced; Anemia; Aspirin; Blood Platelet Disorders; Female; Humans; Infant, Newb | 1971 |
The occurrence and clinical features of analgesic abuse in Western Scotland.
Topics: Adult; Aged; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Sideroblastic; Aspirin; Blood Urea Nitr | 1968 |